Related Experiment Video
Updated: Mar 7, 2026

08:56
Visual Detection of Multiple Nucleic Acids in a Capillary Array
Published on: November 15, 2017
7.8K
Simultaneous Detection of Dual Nucleic Acids Using a SERS-Based Lateral Flow Assay Biosensor.
Xiaokun Wang1, Namhyun Choi1, Ziyi Cheng1
1Department of Bionano Engineering, Hanyang University , Ansan 426-791, South Korea.
Analytical Chemistry
|February 15, 2017
Summary
This study introduces a novel surface-enhanced Raman scattering (SERS)-based lateral flow assay (LFA) for simultaneously detecting dual DNA markers, achieving high sensitivity for early disease diagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Diagnostics
Background:
- Lateral flow assays (LFAs) are widely used for rapid diagnostics.
- Existing methods often lack the sensitivity and multiplexing capabilities for early disease detection.
- Simultaneous detection of multiple biomarkers can improve diagnostic accuracy.
Purpose of the Study:
- To develop a novel SERS-based LFA biosensor for simultaneous dual DNA detection.
- To enhance the sensitivity and quantitative capabilities of LFAs.
- To validate the platform for detecting specific viral DNA markers.
Main Methods:
- Development of an LFA strip with two test lines and one control line.
- Utilized SERS nano tags conjugated with DNA probes for signal amplification.
- Quantitative analysis based on SERS peak intensities for Kaposi's sarcoma-associated herpesvirus (KSHV) and bacillary angiomatosis (BA) DNA.
Main Results:
- Achieved simultaneous detection of dual DNA markers (KSHV and BA).
- Demonstrated high sensitivity with limits of detection at 0.043 pM (KSHV) and 0.074 pM (BA).
- Exhibited approximately 10,000-fold higher sensitivity compared to aggregation-based colorimetric methods.
Conclusions:
- This SERS-based LFA platform enables sensitive simultaneous detection of multiple DNA targets.
- Represents a significant advancement in multiplex DNA sensing for early disease diagnosis.
- Offers a promising tool for developing next-generation diagnostic assays.

